annual FCF:
-$122.78M-$72.56M(-144.48%)Summary
- As of today (May 29, 2025), VRNA annual free cash flow is -$122.78 million, with the most recent change of -$72.56 million (-144.48%) on December 31, 2024.
- During the last 3 years, VRNA annual FCF has fallen by -$89.52 million (-269.09%).
- VRNA annual FCF is now -3611364.71% below its all-time high of $3400.00, reached on December 31, 2005.
Performance
VRNA Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$12.10M+$17.27M(+58.82%)Summary
- As of today (May 29, 2025), VRNA quarterly free cash flow is -$12.10 million, with the most recent change of +$17.27 million (+58.82%) on March 31, 2025.
- Over the past year, VRNA quarterly FCF has increased by +$1.53 million (+11.23%).
- VRNA quarterly FCF is now -153.02% below its all-time high of $22.81 million, reached on September 30, 2021.
Performance
VRNA quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$121.25M+$1.53M(+1.25%)Summary
- As of today (May 29, 2025), VRNA TTM free cash flow is -$121.25 million, with the most recent change of +$1.53 million (+1.25%) on March 31, 2025.
- Over the past year, VRNA TTM FCF has dropped by -$63.19 million (-108.82%).
- VRNA TTM FCF is now -2597.99% below its all-time high of -$4.49 million, reached on March 31, 2017.
Performance
VRNA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
VRNA Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -144.5% | +11.2% | -108.8% |
| 3 y3 years | -269.1% | +16.6% | -314.9% |
| 5 y5 years | -186.1% | +8.6% | -180.7% |
VRNA Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -269.1% | at low | -109.2% | +80.7% | -324.4% | +1.3% |
| 5 y | 5-year | -269.1% | at low | -153.0% | +80.7% | -324.4% | +1.3% |
| alltime | all time | <-9999.0% | at low | -153.0% | +80.7% | -2598.0% | +1.3% |
VRNA Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$12.10M(-58.8%) | -$121.25M(-1.2%) |
| Dec 2024 | -$122.78M(+144.5%) | -$29.37M(-53.1%) | -$122.78M(+18.3%) |
| Sep 2024 | - | -$62.66M(+265.7%) | -$103.81M(+92.7%) |
| Jun 2024 | - | -$17.13M(+25.7%) | -$53.89M(-7.2%) |
| Mar 2024 | - | -$13.63M(+31.0%) | -$58.07M(+15.6%) |
| Dec 2023 | -$50.22M(-16.1%) | -$10.40M(-18.3%) | -$50.22M(+5.6%) |
| Sep 2023 | - | -$12.73M(-40.3%) | -$47.56M(-10.1%) |
| Jun 2023 | - | -$21.31M(+268.6%) | -$52.93M(+3.4%) |
| Mar 2023 | - | -$5.78M(-25.3%) | -$51.16M(-14.6%) |
| Dec 2022 | -$59.89M(+80.0%) | -$7.74M(-57.2%) | -$59.89M(-13.8%) |
| Sep 2022 | - | -$18.09M(-7.4%) | -$69.48M(+143.2%) |
| Jun 2022 | - | -$19.55M(+34.7%) | -$28.57M(-2.3%) |
| Mar 2022 | - | -$14.51M(-16.2%) | -$29.23M(-12.1%) |
| Dec 2021 | -$33.27M(-26.3%) | -$17.32M(-175.9%) | -$33.27M(-4.3%) |
| Sep 2021 | - | $22.81M(-212.9%) | -$34.75M(-48.6%) |
| Jun 2021 | - | -$20.20M(+8.9%) | -$67.62M(+34.0%) |
| Mar 2021 | - | -$18.55M(-1.3%) | -$50.48M(+11.8%) |
| Dec 2020 | -$45.16M(+5.2%) | -$18.80M(+86.8%) | -$45.16M(+19.8%) |
| Sep 2020 | - | -$10.06M(+228.8%) | -$37.70M(+4.3%) |
| Jun 2020 | - | -$3.06M(-76.9%) | -$36.16M(-16.3%) |
| Mar 2020 | - | -$13.23M(+16.6%) | -$43.20M(+0.7%) |
| Dec 2019 | -$42.92M | -$11.35M(+33.2%) | -$42.92M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$8.52M(-15.7%) | -$37.58M(+25.2%) |
| Jun 2019 | - | -$10.11M(-21.9%) | -$30.01M(+9.8%) |
| Mar 2019 | - | -$12.95M(+115.7%) | -$27.33M(+17.2%) |
| Dec 2018 | -$23.32M(-17.5%) | -$6.00M(+532.2%) | -$23.32M(-3.6%) |
| Sep 2018 | - | -$949.50K(-87.2%) | -$24.19M(-28.6%) |
| Jun 2018 | - | -$7.43M(-16.9%) | -$33.86M(+3.5%) |
| Mar 2018 | - | -$8.94M(+30.0%) | -$32.71M(+15.7%) |
| Dec 2017 | -$28.26M(+300.9%) | -$6.87M(-35.3%) | -$28.26M(+32.1%) |
| Sep 2017 | - | -$10.62M(+69.4%) | -$21.39M(+98.7%) |
| Jun 2017 | - | -$6.27M(+39.6%) | -$10.77M(+139.6%) |
| Mar 2017 | - | -$4.49M | -$4.49M |
| Dec 2016 | -$7.05M(-26.8%) | - | - |
| Dec 2015 | -$9.63M(+64.5%) | - | - |
| Dec 2014 | -$5.85M(+64.2%) | - | - |
| Dec 2013 | -$3.57M(-15.1%) | - | - |
| Dec 2012 | -$4.20M(+69.0%) | - | - |
| Dec 2011 | -$2.49M(-5.7%) | - | - |
| Dec 2010 | -$2.64M(-0.9%) | - | - |
| Dec 2009 | -$2.66M(+32.5%) | - | - |
| Dec 2008 | -$2.01M(-17.1%) | - | - |
| Dec 2007 | -$2.42M(+237.9%) | - | - |
| Dec 2006 | -$717.10K(<-9900.0%) | - | - |
| Dec 2005 | $3400.00 | - | - |
FAQ
- What is Verona Pharma annual free cash flow?
- What is the all time high annual FCF for Verona Pharma?
- What is Verona Pharma annual FCF year-on-year change?
- What is Verona Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Verona Pharma?
- What is Verona Pharma quarterly FCF year-on-year change?
- What is Verona Pharma TTM free cash flow?
- What is the all time high TTM FCF for Verona Pharma?
- What is Verona Pharma TTM FCF year-on-year change?
What is Verona Pharma annual free cash flow?
The current annual FCF of VRNA is -$122.78M
What is the all time high annual FCF for Verona Pharma?
Verona Pharma all-time high annual free cash flow is $3400.00
What is Verona Pharma annual FCF year-on-year change?
Over the past year, VRNA annual free cash flow has changed by -$72.56M (-144.48%)
What is Verona Pharma quarterly free cash flow?
The current quarterly FCF of VRNA is -$12.10M
What is the all time high quarterly FCF for Verona Pharma?
Verona Pharma all-time high quarterly free cash flow is $22.81M
What is Verona Pharma quarterly FCF year-on-year change?
Over the past year, VRNA quarterly free cash flow has changed by +$1.53M (+11.23%)
What is Verona Pharma TTM free cash flow?
The current TTM FCF of VRNA is -$121.25M
What is the all time high TTM FCF for Verona Pharma?
Verona Pharma all-time high TTM free cash flow is -$4.49M
What is Verona Pharma TTM FCF year-on-year change?
Over the past year, VRNA TTM free cash flow has changed by -$63.19M (-108.82%)